| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3977752 | Brachytherapy | 2012 | 7 Pages |
Abstract
Our data suggest that a PSA percentage >20% of pretreatment value at 6 months might represent an early, inexpensive, and useful predictive tool of bad outcome in patients after permanent brachytherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mauro Paoluzzi, Marcello Mignogna, Elena Lorenzini, Francesca Valent, Nicola Fontana, Novello Pinzi, Fabrizio Repetti, Roberto Ponchietti,